These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Differential effects of central serotonin manipulation on hyperactive and stereotyped behaviour. Carter CJ; Pycock CJ Life Sci; 1978 Sep; 23(9):953-60. PubMed ID: 568208 [No Abstract] [Full Text] [Related]
26. Proceedings: The effects of buprenorphine, morphine and pentazocine on turning behaviour and stereotypy induced by apomorphine in the rat. Cowan A; Dettmar PW; Walter DS J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():15P. PubMed ID: 2687 [No Abstract] [Full Text] [Related]
27. Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics. Barghon R; Protais P; Colboc O; Costentin J Neurosci Lett; 1981 Nov; 27(1):69-73. PubMed ID: 6120489 [TBL] [Abstract][Full Text] [Related]
28. Influences of estrogen and/or progesterone on some dopamine related behavior in rats. Palermo-Neto J; Dorce VA Gen Pharmacol; 1990; 21(1):83-7. PubMed ID: 2298391 [TBL] [Abstract][Full Text] [Related]
30. Effects of buspirone on dopaminergic supersensitivity. Queiroz CM; Frussa-Filho R Life Sci; 1997; 61(4):371-82. PubMed ID: 9244363 [TBL] [Abstract][Full Text] [Related]
31. Behavioral effects of apomorphine during development of rats. Brus R; Herman ZS; Jamrozik Z Acta Physiol Pol; 1977; 28(3):243-6. PubMed ID: 561515 [TBL] [Abstract][Full Text] [Related]
32. Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice. Kuschinsky K; Hornykiewicz O Eur J Pharmacol; 1974 Apr; 26(1):41-50. PubMed ID: 4598755 [No Abstract] [Full Text] [Related]
33. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist. Bartoszyk GD; Harting J; Minck KO J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454 [TBL] [Abstract][Full Text] [Related]
34. Effect of morphine on brain apomorphine concentrations in the rat. Symes AL; Lal S; Sourkes TL J Pharm Pharmacol; 1977 Jan; 29(1):44-5. PubMed ID: 13182 [No Abstract] [Full Text] [Related]
35. Does individually different sensitivity to dopaminergic stimulation determine the degree of tolerance and dependence to opioids? Havemann U Pharmacopsychiatry; 1988 Nov; 21(6):314-6. PubMed ID: 2907636 [No Abstract] [Full Text] [Related]
36. Effect of manipulation of the GABA system on dopamine-related behaviors. Sandoval MR; Palermo-Neto J Braz J Med Biol Res; 1995 Jan; 28(1):88-99. PubMed ID: 7581034 [TBL] [Abstract][Full Text] [Related]
37. Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics. Malec D; Fidecka S; Langwiński R Pol J Pharmacol Pharm; 1977; 29(3):177-93. PubMed ID: 560683 [TBL] [Abstract][Full Text] [Related]
38. The interaction of clonidine with dopamine-dependent behaviour in rodents. Pycock CJ; Jenner PG; Marsden CD Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):133-41. PubMed ID: 558529 [TBL] [Abstract][Full Text] [Related]
39. Effects of chronic morphine treatment on dopamine-mediated turning behaviour in rats and mice with 6-hydroxydopamine-induced unilateral nigro-striatal lesions. Slater P; Crossman AR Neuropharmacology; 1980 Mar; 19(3):289-95. PubMed ID: 7191487 [No Abstract] [Full Text] [Related]
40. Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock (ECS) in rats. Wielosz M Neuropharmacology; 1981 Oct; 20(10):941-5. PubMed ID: 7197762 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]